Sign in

CIK 0001714899

  • Large accelerated filer

Denali Therapeutics Inc.

Sign in to watch
Ticker
DNLI
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
463872213
Phone
+1 650-866-8547
Business address
161 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA, 94080
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Open-market sale COO and Secretary sold 7,500 shares at an average $22.05 ($165,350)
  10. 4 Open-market sale Chief Medical Officer sold 17,500 shares at an average $22.85 ($399,901)
  11. 4/A Open-market sale Chief Medical Officer sold 36,912 shares at an average $25.44 ($938,976)
  12. 4 Open-market sale President and CEO sold 18,334 shares at an average $24.20 ($443,744)
  13. 4 Open-market sale COO and Secretary sold 7,500 shares at an average $28.05 ($210,396)
  14. 4 Other disposition 10% owner disposed of 158,764 shares (other)
  15. 4 Open-market sale Chief Medical Officer sold 9,588 shares at an average $26.35 ($252,678)
  16. 4 Open-market sale Chief Medical Officer sold 36,805 shares at an average $25.44 ($936,285)
  17. 4 Open-market sale President and CEO sold 18,333 shares at an average $25.03 ($458,800)
  18. 4 Open-market sale Chief Medical Officer sold 1,000 shares at $25.01 ($25,010)
  19. 4 Open-market sale COO and Secretary sold 7,500 shares at an average $22.58 ($169,313)
  20. 4 Open-market sale Chief Medical Officer sold 17,500 shares at an average $22.17 ($388,000)

Page 18 of 22 · 436 filings